SSSD 2023

/ SSSD2023/

57th Annual Meeting of the Scandinavian Society for the Study of Diabetes (SSSD2023) in Aarhus

The registration for the 57th Annual Meeting of the Scandinavian Society for the Study of Diabetes (SSSD2023) in Aarhus, Denmark is now open https://ddeacademy.dk/events/57th-annual-meeting-scandinavian-society-study-diabetes-sssd2023. The Annual Meeting will be held 24-26 May 2023 at the new Steno Diabetes Center Aarhus.

We encourage all researchers/clinicians working within any field of diabetes to participate. Participants are encouraged to submit abstracts, and participation is guaranteed for all who have submitted an abstract. All accepted abstracts will be presented orally with two Outstanding Presentation Awards each of 5000 NOK awarded to the two best presentations.

The program will alternate between invited talks within different areas of diabetes research (complications, epidemiology, appetite regulation, adipose tissue, glucagon, lifestyle interventions), and short oral presentations from participants.

Priority will be given to networking and social events, which will be incorporated throughout the meeting, to facilitate and strengthen collaborative relationships. During the meeting, the annual SSSD research prizes are awarded with presentations from the prize recipients (Knud Lundbæk Award, SSSD Young Investigator Award, Novo Nordisk Foundation Lecture Prize and The Swedish Child Diabetes Foundation Nordic Prize).

Public Defence January 19: Archana Sharma

/

Cand.med. Archana Sharma at Institute of Clinical Medicine will be defending the thesis “Glucose metabolism in South Asian and Nordic women with previous gestational diabetes mellitus” for the degree of PhD (Philosophiae Doctor).

Time and place: Jan. 19, 2023 12:15 PM, Store auditorium (Frontbygget), Akershus Universitetssykehus, Sykehusveien 25, Lørenskog

For more information, click Public Defence: Archana Sharma - Institute of Clinical Medicine (uio.no)

Important novel data from the EPIPREG study presented in the prestigious journal Diabetes

/

With data from the EPIPREG sample, we identified six cross-ancestry CpG sites related to insulin resistance in pregnancy, whereof five were replicated in independent studies. From methylation quantitative trait loci analysis, we identified gene variants related to all five replicated cross-ancestry CpG sites, which were associated with several cardiometabolic phenotypes. Mediation analyses suggested that the gene variants regulate insulin resistance through DNA methylation.

DIABETES, December 19th 2022, online ahead of print: Click here

Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study

/

Using data from 24 population-based data sources from Europe, Asia, North America, and Oceania, we estimated the lifetime risk of type 2 diabetes, life expectancy in people with and without type 2 diabetes, and years of life lost to type 2 diabetes. With the incidence of type 2 diabetes declining in the high-income setting, there has been a corresponding decrease in lifetime risk in many high-income jurisdictions.

However, the burden of diabetes remains high. This substantial individual burden should be considered in future public health strategy and emphasised in patient counselling to improve health outcomes for people with type 2 diabetes.

THE LANCET Diabetes and Endocrinology VOLUME 10, ISSUE 11, NOVEMBER 01, 2022